Logo
Login
$PDSB
$1.52 +$0.22 (16.92%) Close

Ownership

13F as of Q2 2026 · 56.0M shares outstanding

Who owns PDSB?

By type of holder
Institutions 13.7% Insiders 23.5% Everyone else 62.8%
Concentration Top 10 holders own 82.0%
Nant Capital, LLC 36.3% · Patrick Soon-Shiong 36.3%
Institutional ownership
13.7%
+4.7 pts vs last qtr
Institutional holders
51
+10 vs last qtr
Net shares bought
+2.6M
by institutions in Q2 2026
New / sold out
15 / 5
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Quantinno Capital Management LP NEW +642.2K
  • Focus Partners Wealth NEW +642.2K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Armistice Capital, LLC SOLD OUT −173.6K
  • Geode Capital Management, LLC −73.1K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for PDS Biotechnology Corp in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025
+177.0%
+22.60% a year
Each share's claim on the business
−63.9%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $28.3M
over 6 fiscal years
Diluted shares, split-adjusted
16.2M31.5M46.8M2020: 16.7M shares'202021: 25.6M shares'212022: 28.6M shares'222023: 31.0M shares'232024: 36.5M shares'242025: 46.4M shares'25
Buybacks Stock-based comp
$0$3.8M$7.6M2020 buybacks: $02020 stock comp: $432.3K'202021 buybacks: $02021 stock comp: $4.1M'212022 buybacks: $02022 stock comp: $5.2M'222023 buybacks: $02023 stock comp: $7.6M'232024 buybacks: $02024 stock comp: $6.8M'242025 buybacks: $02025 stock comp: $4.1M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years55% 3–5 years1% 1–3 years9% Under 1 year35%
Quarterly turnover
33.9%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting PDSB on Form 13F
VC
Vanguard Capital Management LLC
Shares
1.7M
% of company
3.04%
Change vs last qtr
+68.2K (+4.2%)
Held since
≤2021
GC
Geode Capital Management, LLC
Shares
587.1K
% of company
1.05%
Change vs last qtr
−73.1K (−11.1%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding PDS Biotechnology Corp, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting PDSB on Form N-PORT; together they hold 4.3% of the company
VT
Vanguard Total Stock Market Index Fund
Vanguard Index Funds
Position value
$918K
% of company
1.86%
% of the fund
0.00%
As of
June 30, 2026
VE
Vanguard Extended Market Index Fund
Vanguard Index Funds
Position value
$515K
% of company
1.04%
% of the fund
0.00%
As of
June 30, 2026

10 more funds behind a free account

See every fund holding PDS Biotechnology Corp and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
NC
Nant Capital, LLC
5%+ holder13D · 19.9%
Shares
20.3M
% of company
36.33%
Change vs last qtr
—
Held since
—
PS
Patrick Soon-Shiong
5%+ holder13D · 19.9%
Shares
20.3M
% of company
36.33%
Change vs last qtr
—
Held since
—

3 more holders behind a free account

See every insider and 5%+ holder of PDS Biotechnology Corp.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans